Skip to main content

Plasma therapy test trials continue

By Abdul Qadir Qureshi
(Pakistan News & Features Services)

A new clinical trial evaluating the efficacy and safety of plasma therapy, an emerging form of treatment for the coronavirus, in Pakistani COVID-19 patients is underway at the Aga Khan University (AKU) in Karachi. 

Convalescent plasma therapy involves separating blood donated by previous COVID-19 patients into plasma, a clear straw-coloured liquid, that contains antibodies and proteins that help fight infections. 

The plasma is then injected into a severely ill COVID-19 patient whose immune system may not be able to generate the antibodies needed to combat the virus. A single donation can potentially treat two patients.

There is currently no vaccine for the coronavirus and no approved form of treatment beyond managing its symptoms. The trial will generate evidence on whether plasma therapy, the only experimental treatment currently available for the virus, can help treat those suffering from acute complications from the virus. 

The researchers will perform three pre-procedural investigations on each donor to ensure their blood is safe from other infections and to check their suitability for the process of apheresis which collects plasma. 

Like a typical blood donation, the process is painless after the initial prick and lasts approximately two hours. Once plasma is transfused into a patient, the team will monitor the response to the treatment and assess its effectiveness through clinical and laboratory tests. Informed consent will be sought from all potential donors as well as those receiving the treatment. 

“Plasma therapy can potentially help treat patients with moderate to severe COVID-19 infection,” Dr Natasha Ali, who is part of a team of six faculty members from the departments of Pathology and Laboratory Medicine, and Internal Medicine, working on the trial, remarked.

“This trial is part of the University’s science-based approach to evaluating novel treatments that can help save lives during this pandemic,” she added. 

The AKU is also participating in Solidarity, the international clinical trial launched by the World Health Organization (WHO) and its partners, to find effective treatments for the coronavirus. 

The study has been approved by the Drug Regulatory Authority of Pakistan and Pakistan’s National Bioethics Committee.
Labels:

Comments

Post a Comment

Popular posts from this blog

KDSP: Empowering Individuals with Down Syndrome in Karachi

The Karachi Down Syndrome Program (KDSP), a beacon of hope and support, is making significant strides in empowering individuals with Down syndrome in the city. Founded in March 2014 by a group of passionate parents and individuals, KDSP addresses the critical need for comprehensive resources and platforms for those with Down syndrome in Karachi. Bridging the Gap: A Mission of Advocacy and Inclusion KDSP operates as a non-profit organization with a clear mission: to advocate for the value, acceptance, and inclusion of individuals with Down syndrome. Recognizing the limited support and resources available locally, KDSP was established to provide a nurturing environment where individuals with Down syndrome can lead independent and fulfilling lives. A Lifelong Journey of Support Understanding the unique needs of individuals with Down syndrome and their families, KDSP offers unwavering support from the moment a family receives a diagnosis.  They embark on a journey with each family, pro...
Post a Comment
Read more

Akbar Ali Khan elected AMUOBA President, appointed SSUET Chancellor

  By Abdul Qadir Qureshi (Pakistan News & Features Services) Akbar Ali Khan, son of the distinguished Engr Zakir Ali Khan, has been elected as the President of the Aligarh Muslim University Old Boys Association (AMUOBA), thereby assuming the position of Chancellor at Sir Syed University of Engineering and Technology (SSUET). He succeeds Jawaid Anwar as the university’s fourth Chancellor. SSUET was established in 1993 under the leadership of its founding Chancellor, Engr Z A Nizami. Following his passing in 2013, the role was subsequently held by Engr Adil Usman and Jawaid Anwar. Akbar Ali Khan now takes over this prestigious position, continuing his family’s legacy of service to the institution. The AMUOBA elections, held after a decade, witnessed the Zakir Ali Khan Panel securing victory over the Alig United Panel with a margin of 158 to 130 votes. Following his election, Akbar Ali Khan chaired the first Executive Committee meeting of AMUOBA, during which key office bearers we...
Post a Comment
Read more

Ambassador explains Chinese role in curbing COVID-19

By Masood Sattar Khan  (Pakistan News & Features Services) The Chinese Ambassador to Pakistan, Yao Jing, attended the preparation and response plan of the new crown epidemic on April 24. According to the details shared by the Chinese Embassy in Islamabad, Ambassador Yao Jing was invited to attend the Pakistan New Crown Outbreak Preparation and Response Plan (PPRP) on video conference. The meeting, organized by the Pakistani Ministry of Foreign Affairs, was also attended by Foreign Minister Shah Mahmood Qureshi, Minister of Economic Affairs, Khasro Bakhtiar, Prime Minister’s Health Adviser Dr Zafar Mirza, Chairman of the National Disaster Management Authority, General Muhammad Afzal, WHO Director-General, Tan Desai besides the representatives of World Bank, United Nations, UNICEF, UNHCR, Asian Development Bank, Islamic Development Bank and envoys from more than 20 countries.  Besides China, envoys from the United States, the United Kingdom, France, Canada, the European Unio...
Post a Comment
Read more